168 related articles for article (PubMed ID: 35785107)
1. Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System.
Christoffel L; Bends R; Toub D; Schiermeier S; Pschadka G; Engelhardt M; Quinn S; Hartmann M; Habiba M; Felberbaum R; Brössner A; Schippert C; Römer T
J Gynecol Surg; 2022 Jun; 38(3):207-213. PubMed ID: 35785107
[TBL] [Abstract][Full Text] [Related]
2. Transcervical Fibroid Ablation (TFA): Update on Pregnancy Outcomes.
Hansen-Lindner L; Schmid-Lossberg J; Toub D
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792434
[No Abstract] [Full Text] [Related]
3. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.
Shifrin G; Engelhardt M; Gee P; Pschadka G
Int J Gynaecol Obstet; 2021 Oct; 155(1):79-85. PubMed ID: 33544889
[TBL] [Abstract][Full Text] [Related]
4. Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.
Christoffel L; Römer T; Schiermeier S
Med Devices (Auckl); 2021; 14():77-84. PubMed ID: 33688276
[TBL] [Abstract][Full Text] [Related]
5. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata.
Lukes A; Green MA
J Gynecol Surg; 2020 Oct; 36(5):228-233. PubMed ID: 33061253
[No Abstract] [Full Text] [Related]
6. The INTEGRITY Trial: Preservation of Uterine-Wall Integrity 12 Months After Transcervical Fibroid Ablation with the Sonata System.
Bongers M; Gupta J; Garza-Leal JG; Brown M; Felberbaum R
J Gynecol Surg; 2019 Oct; 35(5):299-303. PubMed ID: 31602171
[No Abstract] [Full Text] [Related]
7. Evaluation of uterine patency following transcervical uterine fibroid ablation with the Sonata system (the OPEN clinical trial).
Bongers M; Quinn SD; Mueller MD; Krämer B; Tuschy B; Sütterlin M; Bassil Lasmar R; Chudnoff S; Thurkow A; De Wilde RL
Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():122-125. PubMed ID: 31580964
[TBL] [Abstract][Full Text] [Related]
8. 12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids.
Hudgens J; Johns DA; Lukes AS; Forstein DA; Delvadia D
Int J Womens Health; 2019; 11():387-394. PubMed ID: 31308763
[TBL] [Abstract][Full Text] [Related]
9. Term Delivery in an Infertile Patient after Transcervical Radiofrequency Fibroid Ablation and Assisted Reproductive Technology.
Pschadka G; Engelhardt M; Niehoff C; Toub D
J Gynecol Surg; 2019 Aug; 35(4):253-255. PubMed ID: 31406455
[No Abstract] [Full Text] [Related]
10. Durable Improvement in Generic and Fibroid-Specific Quality of Life in Women Treated with Transcervical Fibroid Ablation with the Sonata System After Three Years.
Roy K; Robinson JK
J Gynecol Surg; 2022 Apr; 38(2):143-147. PubMed ID: 35497488
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the Sonata System: a retrospective follow-up study.
van der Meulen JF; Cooijmans TH; van Zutven VJ; Leemans JC; Verhoeven CJ; Bongers MY
AJOG Glob Rep; 2022 Nov; 2(4):100087. PubMed ID: 36536842
[TBL] [Abstract][Full Text] [Related]
12. Transcervical Radiofrequency Ablation of Symptomatic Uterine Fibroids: 2-Year Results of the SONATA Pivotal Trial.
Miller CE; Osman KM
J Gynecol Surg; 2019 Dec; 35(6):345-349. PubMed ID: 32226268
[No Abstract] [Full Text] [Related]
13. Transcervical radiofrequency ablation of fibroids that are 5 cm or larger in women with abnormal uterine bleeding.
Piriyev E; Schiermeier S; Bends R; Römer T
J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102303. PubMed ID: 34973479
[TBL] [Abstract][Full Text] [Related]
14. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids.
Brölmann H; Bongers M; Garza-Leal JG; Gupta J; Veersema S; Quartero R; Toub D
Gynecol Surg; 2016; 13():27-35. PubMed ID: 26918001
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study.
Garza-Leal JG
J Gynecol Surg; 2019 Feb; 35(1):19-23. PubMed ID: 30713407
[No Abstract] [Full Text] [Related]
16. The CHOICES Study: Facility Level Comparative Cost, Resource Utilization, and Outcomes Analysis of Myomectomy Compared to Transcervical Fibroid Ablation.
Brooks EA; Singer AM; Delvadia DR; Forstein D; Beaudoin TJ; Bauserman RL; Yuen MW; Little CA; Zambelli-Weiner A
Clinicoecon Outcomes Res; 2020; 12():299-306. PubMed ID: 32606846
[TBL] [Abstract][Full Text] [Related]
17. A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System.
Toub DB
Curr Obstet Gynecol Rep; 2017; 6(1):67-73. PubMed ID: 28357157
[TBL] [Abstract][Full Text] [Related]
18. Normal spontaneous vaginal delivery after transcervical radiofrequency ablation of uterine fibroids: a case report.
Bends R; Toub DB; Römer T
Int J Womens Health; 2018; 10():367-369. PubMed ID: 30038526
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency Ablation of Uterine Myomas and Pregnancy Outcomes: An Updated Review of the Literature.
Polin M; Hur HC
J Minim Invasive Gynecol; 2022 Jun; 29(6):709-715. PubMed ID: 35123041
[TBL] [Abstract][Full Text] [Related]
20. Case Series of Reproductive Outcomes after Laparoscopic Radiofrequency Ablation of Symptomatic Myomas.
Berman JM; Shashoua A; Olson C; Brucker S; Thiel JA; Bhagavath B
J Minim Invasive Gynecol; 2020; 27(3):639-645. PubMed ID: 31238151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
